Study of Paclitaxel in Patients With Ovarian Cancer
Phase 3
Completed
- Conditions
- Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
- Interventions
- Drug: Paclical®
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Oasmia Pharmaceutical AB
- Target Recruit Count
- 789
- Registration Number
- NCT00989131
- Locations
- 🇧🇬
Regional Oncology Dispensary, Stara Zagora, Bulgaria
🇭🇺B.-A.-Z. Megyei Kórház és Egyetemi Oktató Kórház, Észak-Kelet Magyarországi Regionális Klinikai Farmakológiai Központ, Miskolc, Hungary
🇭🇷Klinikčki Bolnički Centar Zagreb, Zagreb, Croatia
© Copyright 2025. All Rights Reserved by MedPath